Biogen (BIIB) Free Cash Flow (2009 - 2026)

Biogen's Free Cash Flow history runs 18 years deep, the most recent figure standing at $594.3 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 167.46% year-over-year to $594.3 million; the TTM figure through Mar 2026 stood at $2.4 billion (down 0.57% YoY), while the FY2025 annual figure was $2.1 billion, down 24.65% from the prior year.
• Free Cash Flow was $594.3 million for Q1 2026 at Biogen, up from $468.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $1.2 billion in Q3 2025 to a low of -$261.4 million in Q4 2022.
• Historically, Free Cash Flow has averaged $457.7 million across 5 years, with a median of $507.3 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 133.23% in 2022, then jumped 1469.26% in 2024.
• A 5-year view of Free Cash Flow shows it stood at -$261.4 million in 2022, then jumped by 79.84% to -$52.7 million in 2023, then surged by 1469.26% to $721.6 million in 2024, then slumped by 35.14% to $468.0 million in 2025, then gained by 26.99% to $594.3 million in 2026.
• The last three Free Cash Flow figures came in at $594.3 million (Q1 2026), $468.0 million (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.